← Leaderboards
Jing Zhang
Whitehead Institute For Biomedical Res
$8,366,020
Attributed
$8,366,020
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $956.9K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,366,020 · 4
By mechanism
R01$7,607,255 · 3
K01$758,765 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadOncogenicPathway InteractionsMolecularMutationSignal TransductionHematopoietic Stem CellsCellsGeneticIn VivoMeksSamplingMalignant NeoplasmsMediatingAffectMouse ModelGenesHypersensitivityInsightSignal PathwayIn VitroMyeloproliferative DiseaseDiagnosisLeukemia
Grant awards (27)
Molecular and Cellular Mechanisms of Mutant ASXL1-driven Clonal Hematopoiesis$545,908
R01 · FY2025 · AG · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$406,245
R01 · FY2025 · CA · contact PI
Molecular and Cellular Mechanisms of Mutant ASXL1-driven Clonal Hematopoiesis$570,922
R01 · FY2024 · AG · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$385,932
R01 · FY2024 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$406,245
R01 · FY2023 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$370,624
R01 · FY2021 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$568,895
R01 · FY2020 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$353,933
R01 · FY2019 · CA · contact PI
The role of TCOF1 in germline predisposition to and in leukemic transformation of chronic myelomonocytic leukemia$215,707
R01 · FY2019 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$373,634
R01 · FY2018 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$378,849
R01 · FY2017 · CA · contact PI
Dose-dependent Activation of the MEK/ERK Pathway in Hematopoiesis$372,210
R01 · FY2016 · HL · contact PI
Dose-dependent Activation of the MEK/ERK Pathway in Hematopoiesis$366,626
R01 · FY2015 · HL · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$312,288
R01 · FY2015 · CA · contact PI
Dose-dependent Activation of the MEK/ERK Pathway in Hematopoiesis$364,766
R01 · FY2014 · HL · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$321,500
R01 · FY2014 · CA · contact PI
Dose-dependent Activation of the MEK/ERK Pathway in Hematopoiesis$354,344
R01 · FY2013 · HL · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$300,551
R01 · FY2013 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$322,288
R01 · FY2012 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$3,500
R01 · FY2012 · CA · contact PI
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)$312,288
R01 · FY2011 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$144,801
K01 · FY2011 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$163,350
K01 · FY2010 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$163,350
K01 · FY2009 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$163,350
K01 · FY2008 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$90,193
K01 · FY2007 · CA · contact PI
Oncogenic K-ras/downstream signaling pathways in hematopoietic progenitors$33,721
K01 · FY2007 · CA · contact PI